164 related articles for article (PubMed ID: 10198735)
21. Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents.
Feldman DN; Wong SC; Gade CL; Gidseg DS; Bergman G; Minutello RM
Am Heart J; 2007 Oct; 154(4):695-701. PubMed ID: 17892994
[TBL] [Abstract][Full Text] [Related]
22. Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT).
Islam MA; Blankenship JC; Balog C; Iliadis EA; Lincoff AM; Tcheng JE; Califf RM; Topol EJ;
Am J Cardiol; 2002 Nov; 90(9):916-21. PubMed ID: 12398954
[TBL] [Abstract][Full Text] [Related]
23. Low incidence of minor myocardial damage associated with coronary stenting detected by serum troponin T comparable to that with balloon coronary angioplasty.
Ohnishi N; Iwasaki K; Kusachi S; Hirami R; Matano S; Ohnishi H; Takeda K; Kita T; Sakakibara N; Tsuji T
Jpn Heart J; 1998 Mar; 39(2):139-46. PubMed ID: 9687822
[TBL] [Abstract][Full Text] [Related]
24. Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome.
Uretsky BF; Birnbaum Y; Osman A; Gupta R; Paniagua O; Chamoun A; Pohwani A; Lui C; Lev E; McGehee T; Kumar D; Akhtar A; Anzuini A; Schwarz ER; Wang FW
Catheter Cardiovasc Interv; 2008 Oct; 72(4):488-97. PubMed ID: 18814223
[TBL] [Abstract][Full Text] [Related]
25. Minimal myocardial damage during coronary intervention is associated with impaired outcome.
Simoons ML; van den Brand M; Lincoff M; Harrington R; van der Wieken R; Vahanian A; Rutsch W; Kootstra J; Boersma E; Califf RM; Topol E
Eur Heart J; 1999 Aug; 20(15):1112-9. PubMed ID: 10413641
[TBL] [Abstract][Full Text] [Related]
26. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions.
Abdelmeguid AE; Topol EJ; Whitlow PL; Sapp SK; Ellis SG
Circulation; 1996 Oct; 94(7):1528-36. PubMed ID: 8840840
[TBL] [Abstract][Full Text] [Related]
27. Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices.
Kini A; Kini S; Marmur JD; Bertea T; Dangas G; Cocke TP; Sharma SK
Catheter Cardiovasc Interv; 1999 Oct; 48(2):123-9. PubMed ID: 10506764
[TBL] [Abstract][Full Text] [Related]
28. Relation of clinical presentation, stenosis morphology, and operator technique to the procedural results of rotational atherectomy and rotational atherectomy-facilitated angioplasty.
Ellis SG; Popma JJ; Buchbinder M; Franco I; Leon MB; Kent KM; Pichard AD; Satler LF; Topol EJ; Whitlow PL
Circulation; 1994 Feb; 89(2):882-92. PubMed ID: 8313578
[TBL] [Abstract][Full Text] [Related]
29. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention.
Kini A; Marmur JD; Kini S; Dangas G; Cocke TP; Wallenstein S; Brown E; Ambrose JA; Sharma SK
J Am Coll Cardiol; 1999 Sep; 34(3):663-71. PubMed ID: 10483945
[TBL] [Abstract][Full Text] [Related]
30. [Periprocedural myocardial damage: chronicle of a (cellular) death foretold].
Galli M; Ebert AG
Ital Heart J Suppl; 2002 Mar; 3(3):265-9. PubMed ID: 12040841
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of myocardial enzyme release after coronary interventions.
Kelly D; Arora R
Catheter Cardiovasc Interv; 1999 Mar; 46(3):292-302. PubMed ID: 10348125
[TBL] [Abstract][Full Text] [Related]
32. [Mechanism of troponin and CK-MB release after percutaneous coronary interventions].
Mongiardo A; Ferraro A; Ceravolo R; Mascaro G; Curcio A; Campopiano E; Indolfi C
Ital Heart J Suppl; 2002 Mar; 3(3):270-4. PubMed ID: 12040842
[TBL] [Abstract][Full Text] [Related]
33. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts.
Safian RD; Grines CL; May MA; Lichtenberg A; Juran N; Schreiber TL; Pavlides G; Meany TB; Savas V; O'Neill WW
Circulation; 1994 Jan; 89(1):302-12. PubMed ID: 8281662
[TBL] [Abstract][Full Text] [Related]
34. Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitors.
De Luca G; Gibson MC; Hof AW; Cutlip D; Zeymer U; Noc M; Maioli M; Zorman S; Gabriel MH; Secco GG; Emre A; Dudek D; Rakowski T; Gyongyosi M; Huber K; Bellandi F;
J Cardiovasc Med (Hagerstown); 2013 Nov; 14(11):815-20. PubMed ID: 23519096
[TBL] [Abstract][Full Text] [Related]
35. Creatine kinase release after successful percutaneous transluminal coronary angioplasty.
Oh JK; Shub C; Ilstrup DM; Reeder GS
Am Heart J; 1985 Jun; 109(6):1225-31. PubMed ID: 3159245
[TBL] [Abstract][Full Text] [Related]
36. [Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention].
Patti G; Pasceri V; Nusca A; Di Sciascio G
Ital Heart J Suppl; 2005 Sep; 6(9):553-60. PubMed ID: 16281714
[TBL] [Abstract][Full Text] [Related]
37. Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. EPILOG Investigators. Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Receptor Blockade.
Ghaffari S; Kereiakes DJ; Lincoff AM; Kelly TA; Timmis GC; Kleiman NS; Ferguson JJ; Miller DP; Califf RA; Topol EJ
Am J Cardiol; 1998 Jul; 82(1):7-12. PubMed ID: 9671000
[TBL] [Abstract][Full Text] [Related]
38. Troponin T, creatine kinase MB mass, and creatine kinase MB isoform ratio in the detection of myocardial damage during non-surgical coronary revascularization.
Reimers B; Lachin M; Cacciavillani L; Secchiero S; Ramondo A; Isabella G; Marzari A; Zaninotto M; Plebani M; Chioin R; Maddalena F; Dalla-Volta S
Int J Cardiol; 1997 Jun; 60(1):7-13. PubMed ID: 9209933
[TBL] [Abstract][Full Text] [Related]
39. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients.
Stone GW; Mehran R; Dangas G; Lansky AJ; Kornowski R; Leon MB
Circulation; 2001 Aug; 104(6):642-7. PubMed ID: 11489768
[TBL] [Abstract][Full Text] [Related]
40. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
Adgey AA
Eur Heart J; 1998 Apr; 19 Suppl D():D10-21. PubMed ID: 9597518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
